| Basics |
IQVIA Holdings Inc.
IQVIA Holdings Inc is an information and technology-enabled healthcare service provider to the pharmaceutical services, biotechnology, and healthcare industries. The Commercial Solutions and Research and Development Solutions generate maximum revenue.
|
| IPO Date: |
May 9, 2013 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$41.1B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$2.15 | 1.19%
|
| Avg Daily Range (30 D): |
$2.27 | 1.00%
|
| Avg Daily Range (90 D): |
$2.58 | 1.23%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.03M |
| Avg Daily Volume (30 D): |
.98M |
| Avg Daily Volume (90 D): |
1.11M |
| Trade Size |
| Avg Trade Size (Sh.): |
54 |
| Avg Trade Size (Sh.) (30 D): |
39 |
| Avg Trade Size (Sh.) (90 D): |
39 |
| Institutional Trades |
| Total Inst.Trades: |
8,857 |
| Avg Inst. Trade: |
$11.72M |
| Avg Inst. Trade (30 D): |
$19.16M |
| Avg Inst. Trade (90 D): |
$17.15M |
| Avg Inst. Trade Volume: |
.07M |
| Avg Inst. Trades (Per Day): |
4 |
| Market Closing Trades |
| Avg Closing Trade: |
$29.74M |
| Avg Closing Trade (30 D): |
$63.43M |
| Avg Closing Trade (90 D): |
$52.66M |
| Avg Closing Volume: |
163.44K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$7.33
|
$1.94
|
$1.55
|
|
Diluted EPS
|
$7.27
|
$1.93
|
$1.54
|
|
Revenue
|
$ 15.9B
|
$ 4.1B
|
$ 4.02B
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ 1.28B
|
$ 332M
|
$ 266M
|
|
Operating Income / Loss
|
$ 2.18B
|
$ 553M
|
$ 506M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 242M
|
$ -225M
|
$ 299M
|
|
PE Ratio
|
0.00
|
|
|
|
|
|
